General Information of the Cell Line
Cell Line ID
CL000393
Cell Line Name
HeLa-MAGI
Synonyms
HeLa MAGI
HeLa Magi
MAGI
HeLa-CD4-LTR-beta-gal
HeLa-CD4-LTR/beta-gal
CD4-LTR/beta-gal
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_D259
Tissue Information
Uterus
Disease
Human papillomavirus-related cervical adenocarcinoma (NCIt: C27677)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00903, C-C chemokine receptor type 5
Compound ID Compound Name Compound Formula
CP0391341
cyclohexyl-[(3S,4S)-3-phenyl-4-[[4-[prop-2-enyl(pyridin-2-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]methanone
   Show/Hide
C31H42N4O
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0391414
(R)-3-Cyclobutyl-2-[(3S,4S)-3-[4-(cyclopropylmethyl-pyrimidin-2-yl-amino)-piperidin-1-ylmethyl]-4-(3-fluoro-phenyl)-pyrrolidin-1-yl]-propionic acid
   Show/Hide
C31H42FN5O2
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0430184
(R)-3-Cyclobutyl-2-{(3S,4S)-3-(3-fluoro-phenyl)-4-[4-(propyl-pyrimidin-2-yl-amino)-piperidin-1-ylmethyl]-pyrrolidin-1-yl}-propionic acid
   Show/Hide
C30H42FN5O2
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0495681
(R)-3-Cyclobutyl-2-{(3S,4S)-3-(3-fluoro-phenyl)-4-[4-(propyl-pyrimidin-5-yl-amino)-piperidin-1-ylmethyl]-pyrrolidin-1-yl}-propionic acid
   Show/Hide
C30H42FN5O2
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0384857
((3S,4S)-3-((4-(allyl(pyridin-3-yl)amino)piperidin-1-yl)methyl)-4-phenylpyrrolidin-1-yl)(cyclohexyl)methanone
   Show/Hide
C31H42N4O
 1
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
CP0408961
((3S,4S)-3-((4-(allyl(pyrimidin-2-yl)amino)piperidin-1-yl)methyl)-4-phenylpyrrolidin-1-yl)(cyclohexyl)methanone
   Show/Hide
C30H41N5O
 1
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
CP0403892
(R)-2-cyclohexyl-2-((3S,4S)-3-phenyl-4-((4-(propyl(pyrimidin-2-yl)amino)piperidin-1-yl)methyl)pyrrolidin-1-yl)acetic acid
   Show/Hide
C31H45N5O2
 1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
CP0408886
(R)-2-cyclohexyl-2-((3S,4S)-3-phenyl-4-((4-(propyl(pyridin-3-yl)amino)piperidin-1-yl)methyl)pyrrolidin-1-yl)acetic acid
   Show/Hide
C32H46N4O2
 1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
CP0414860
(R)-3-Cyclobutyl-2-{(3S,4S)-3-(3-fluoro-phenyl)-4-[4-(propyl-pyrimidin-4-yl-amino)-piperidin-1-ylmethyl]-pyrrolidin-1-yl}-propionic acid
   Show/Hide
C30H42FN5O2
 1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
CP0453521
cyclohexyl-[(3S,4S)-3-[[4-[cyclopropylmethyl(pyridin-2-yl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]methanone
   Show/Hide
C32H44N4O
 1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
CP0502495
(R)-Cyclohexyl-{(3S,4S)-3-(3-fluoro-phenyl)-4-[4-(propyl-pyrimidin-2-yl-amino)-piperidin-1-ylmethyl]-pyrrolidin-1-yl}-acetic acid
   Show/Hide
C31H44FN5O2
 1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
CP0512053
(R)-3-Cyclobutyl-2-((3S,4S)-3-(3-fluoro-phenyl)-4-{4-[(5-fluoro-pyrimidin-2-yl)-propyl-amino]-piperidin-1-ylmethyl}-pyrrolidin-1-yl)-propionic acid
   Show/Hide
C30H41F2N5O2
 1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
CP0444097
((3S,4S)-3-{4-[Allyl-(5-trifluoromethyl-pyridin-2-yl)-amino]-piperidin-1-ylmethyl}-4-phenyl-pyrrolidin-1-yl)-cyclohexyl-methanone
   Show/Hide
C32H41F3N4O
 1
1
IC50 = 37 nM
   TI
   LI
   LO
   TS
CP0406273
cyclohexyl-[(3S,4S)-3-phenyl-4-[[4-[propyl(pyridin-2-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]methanone
   Show/Hide
C31H44N4O
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0406280
(R)-3-Cyclobutyl-2-[(3S,4S)-3-[4-(ethyl-pyrimidin-2-yl-amino)-piperidin-1-ylmethyl]-4-(3-fluoro-phenyl)-pyrrolidin-1-yl]-propionic acid
   Show/Hide
C29H40FN5O2
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0427326
(R)-3-Cyclobutyl-2-((3S,4S)-3-(3-fluoro-phenyl)-4-{4-[propyl-(5-trifluoromethyl-pyrimidin-2-yl)-amino]-piperidin-1-ylmethyl}-pyrrolidin-1-yl)-propionic acid
   Show/Hide
C31H41F4N5O2
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0453222
(R)-3-Cyclobutyl-2-((3S,4S)-3-(3-fluoro-phenyl)-4-{4-[(4-methoxy-pyrimidin-2-yl)-propyl-amino]-piperidin-1-ylmethyl}-pyrrolidin-1-yl)-propionic acid
   Show/Hide
C31H44FN5O3
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0497900
(R)-Cyclohexyl-{(3S,4S)-3-phenyl-4-[4-(propyl-pyridin-2-yl-amino)-piperidin-1-ylmethyl]-pyrrolidin-1-yl}-acetic acid
   Show/Hide
C32H46N4O2
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0384014
(2-Chloro-phenyl)-{(3S,4S)-3-phenyl-4-[4-(propyl-pyridin-2-yl-amino)-piperidin-1-ylmethyl]-pyrrolidin-1-yl}-methanone
   Show/Hide
C31H37ClN4O
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0399795
cyclobutyl-[(3S,4S)-3-phenyl-4-[[4-[propyl(pyridin-2-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]methanone
   Show/Hide
C29H40N4O
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0493787
((3S,4S)-3-phenyl-4-((4-(propyl(pyridin-2-yl)amino)piperidin-1-yl)methyl)pyrrolidin-1-yl)(pyrrolidin-1-yl)methanone
   Show/Hide
C29H41N5O
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0462908
(R)-3-Cyclobutyl-2-((3S,4S)-3-(3-fluoro-phenyl)-4-{4-[propyl-(4-trifluoromethyl-pyrimidin-2-yl)-amino]-piperidin-1-ylmethyl}-pyrrolidin-1-yl)-propionic acid
   Show/Hide
C31H41F4N5O2
 1
1
IC50 = 450 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0071651
4-[[4-(4-benzyl-1H-pyrazol-5-yl)piperidin-1-yl]methyl]pyridine
   Show/Hide
C21H24N4  1
1
TC50 > 300000 nM
   TI
   LI
   LO
   TS
CP0125301
N'-[[(2S)-4-benzylpiperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C25H37N5  1
1
TC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0406573
(3S)-3-[[4-aminobutyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]methyl]-N-phenylpiperazine-1-carboxamide
   Show/Hide
C25H36N6O  1
1
TC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0416320
[(3S)-3-[[4-aminobutyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]methyl]piperazin-1-yl]-phenylmethanone
   Show/Hide
C25H35N5O  1
1
TC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0416321
benzyl (3S)-3-[[4-aminobutyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]methyl]piperazine-1-carboxylate
   Show/Hide
C26H37N5O2  1
1
TC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0425036
N'-[[(2S)-4-naphthalen-2-ylsulfonylpiperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C28H37N5O2S  1
1
TC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0443356
N'-[(4-phenylpiperazin-2-yl)methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C24H35N5  1
1
TC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0450351
N'-[[(2R)-4-benzylpiperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C25H37N5  1
1
TC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0528841
N'-[[(2S)-piperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C18H31N5  1
1
TC50 > 10000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Uterus)
Cell Line Name Organism Disease
C-33 A Homo sapiens (Human) Human papillomavirus-independent cervical squamous cell carcinoma
HeLa Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
H1HeLa Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
L-02 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa S3 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
KB Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
SGC-7901 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa Kyoto Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HL2/3 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
KB-V1 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
BEL-7402/5-FU Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
BGC-823 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
KB-ChR-8-5 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa-MAGI-CCR5 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
P4 MAGI CCR5+ Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
KB-3-1 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
TZM-bl Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
KB-ChR-8-5-11 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
NCTC 2544 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HEp-2 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
SMMC-7721 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HG5LN Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
Chang Liver Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
Girardi Heart Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
MDR-KB-VCR Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
MDR-KB-VIN Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa R1-11 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa-T5 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa/STAT3-luc Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HLR-CREB Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa-A2A Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa-A3 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa-P4 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
C-4-I Homo sapiens (Human) Human papillomavirus-related cervical squamous cell carcinoma
SiHa Homo sapiens (Human) Human papillomavirus-related cervical squamous cell carcinoma
SK-E2 Homo sapiens (Human) Uterine corpus leiomyosarcoma
MES-SA/Dx5 Homo sapiens (Human) Uterine corpus sarcoma
MES-SA Homo sapiens (Human) Uterine corpus sarcoma